(–)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B

Background: Aberrant chronic inflammation and excess accumulation of lipids play a pivotal role in the occurrence and progression of atherosclerosis. (–)-Epigallocatechin-3-gallate (EGCG), the major catechins in green tea, displayed anti-atherosclerotic properties in vivo and in vitro. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Zhang, Zheng-Zhu, Wu, Yan, Wang, Ru-Qing, Chen, Jin-Wu, Chen, Jing, Zhang, Yan, Chen, Ya-Jun, Geng, Ming, Xu, Zhong-Dong, Dai, Min, Li, Jin-Hua, Pan, Li-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854642/
https://www.ncbi.nlm.nih.gov/pubmed/29593532
http://dx.doi.org/10.3389/fphar.2018.00195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854642/
https://www.ncbi.nlm.nih.gov/pubmed/29593532
http://dx.doi.org/10.3389/fphar.2018.00195

Ejemplares similares